Clostridial neurotoxins

Handbook on Clostridia

Volumn , Issue , 2005, Pages 491-526

  Johnson, Eric A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78049312944     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (268)

1. Bleck T.P., Tetanus: pathophysiology, management, and prophylaxis, Disease-a-Month, 37, 547–603, 1991.
2. Cherington, C., Clinical spectrum of botulism, Muscle & Nerve, 21, 701–710, 1998.
3. Montecucco, C. and Schiavo, G., Structure and function of tetanus and botulinum neurotoxins, Quart. Rev. Biophys., 28, 423–472, 1995.
4. Schiavo, G. et al., Neurotoxins affecting neuroexocytosis, Physiol. Rev., 80, 717–766, 2000.
5. Lalli, G. et al., The journey of tetanus and botulinum neurotoxins in neurons, Trends Microbiol., 11, 431–437, 2003.
6. Turton, K., Chaddock, J.A., and Acharya, K.R., Botulinum and tetanus neurotoxins: structure, function, and therapeutic utility, Trends Biochem. Sci., 27, 552–558, 2002.
7. Simpson, L.L., Identification of the major steps in botulinum toxin action, Annu. Rev. Pharmacol. Toxicol., 44, 167–193, 2004.
8. Humeau, Y. et al., How botulinum and tetanus neurotoxins block neurotransmitter release, Biochimie, 82, 427–446, 2000.
9. Drachman, D.B., Botulinum toxin as a tool for research on the nervous system, in Neuropoisons. Their Pathophysiological Actions. Vol. 1. Poisons of Animal Origin, Simpson, L.L., Ed., Plenum Press, New York and London, 1971, 325–347.
10. Arnon S.S. et al., Botulinum toxin as a biological weapon. Medical and public health management, JAMA, 285, 1059–1070, 2001.
11. Caya, J.G., Clostridium botulinum and the ophthalmologist: a review of botulism, including biological warfare ramifications of botulinum toxin, Survey of Ophthamol., 46, 25–34, 2001.
12. Scott, A.B., Clostridial toxins as therapeutic agents, Simpson L.L., Ed., Academic Press, San Diego, 1989, 399–412.
13. Schantz, E.J. and Johnson, E.A., Properties and use of botulinum toxin and other microbial neurotoxins in medicine, Microbiol. Rev., 56, 80–92, 1992.
14. Jankovic, J. and Hallett, M., Therapy with Botulinum Toxin, 4th Edition, Marcel Dekker, New York, 1994.
15. Brin, M.F., Hallett, M., and Jankovic, J., Eds., Scientific and Therapeutic Aspects of Botulinum Toxin, Lippincott, Williams & Williams, Philadelphia, 2002.
16. Johnson, E.A., Clostridial toxins as therapeutic agents: benefits of nature’s most toxic proteins, Annu. Rev. Microbiol., 53, 551–575, 1999.
17. Johnson, E.A. and Bradshaw, M., Clostridium botulinum: A metabolic and cellular perspective, Toxicon, 39, 1703–1722, 2001.
18. Quinn, C.P. and Minton, N.P., Clostridial neurotoxins, in Clostridia; Biotechnology and Medical Applications, Bahl, H. and Dürre, P., Eds., Wiley-VCH, Weinheim, Germany, 2001, 211–250.
19. Brüggeman, H., et al., The genome sequence of Clostridium tetani, the causative agent of tetanus disease, Proc. Natl. Acad. Sci. U.S.A., 100, 1316–1321, 2003.
20. Shimizu, T.K., et al., Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater, Proc. Natl. Acad. Sci. U.S.A., 99, 996–1001, 2002.
21. Smith, L.D.S. and Sugiyama, H., Botulism: The Organism, Its Toxins, the Disease, 2nd Edition, Charles C. Thomas, Springfield, IL, 1988.
22. Simpson, L.L., Botulinum Neurotoxin and Tetanus Toxin, Academic Press, San Diego, 1989.
23. Bahl, H. and Dürre, P., Eds., Clostridia, Biotechnology and Medical Applications, Wiley-VCH, Weinheim, Germany, 2001.
24. Rood, J.L. et al., Eds., The Clostridia, Molecular Biology and Pathogenesis, Academic Press, San Diego, 1997.
25. Montecucco, C., Ed., Clostridial Neurotoxins, Springer, Berlin, 1995.
26. Alouf, J.E. and Freer, J.H., Eds., The Comprehensive Sourcebook of Bacterial Toxins, 2nd Edition, Academic Press, London, 1999.
27. Rappuoli, R. and Montecucco, C., Eds., Guidebook to Protein Toxins and Their Use in Biology, Oxford University Press, Oxford, 1997.
28. van Heyningen, W.E., Bacterial Toxins, Blackwell Scientific, Oxford, 1950.
29. Hatheway, C.L., Toxigenic clostridia, Clin. Microbiol. Rev., 3, 67–98, 1990.
30. Hatheway, C.L. and Johnson, E.A., Clostridium: the spore-bearing anaerobes, in Topley and Wilson’s Microbiology and Microbial Infections, 9th Edition, Volume 2: Systematic Bacteriology, Collier, L., Balows, A., and Sussman, M., Eds., Arnold, London, 1998, 731–782.
31. Johnson, E.A. and Goodnough, M.C., Botulism, in Topley and Wilson’s Microbiology and Microbial Infections, 9th Edition, Volume 3: Bacterial Infections. Collier, L., Balows, A., and Sussman, M. Eds., Arnold, London, 1998, 723–741.
32. Arnon, S.S., Botulism as an intestinal toxemia, in Infections of the Gastrointestinal Tract, Blaser, M.J. et al., Eds., Raven Press, New York, 1995, 257–271.
33. Arnon, SS, Infant botulism, in Textbook of Pediatric Infectious Diseases, 5th Edition, Feigen, R.D., Cherry, J.D., Eds., W.B. Saunders, Philadelphia, 2004.
34. Cook, T.M., Protheroe, R.T., and Handel, J.M., Tetanus: a review of the literature, Brit. J. Anasthesia, 87, 477–487, 2001.
35. Carle, A. and Rattone, G., Studio experimentale sull’ eziologia del tetano, G. Acad. Med. Torino, 32, 174, 1884.
36. Bytchenko, B., Microbiology of tetanus, in Tetanus, Important New Concepts, Veronesi, R., Ed., Excerpta Medica, Amsterdam, 1981, 28–39.
37. Nicolaier, A., Ueber infectiosen tetanus, Dtsch. Med. Wochenschr., 10, 842–844, 1884.
38. Kitasato, S., Über den Tetanusbacillus, Z. Hyg., 7, 224–234, 1889.
39. Finegold, S.M., Tetanus, in Topley and Wilson’s Microbiology and Microbial Infections, 9th Edition, Volume 3: Bacterial Infections, Collier, L., Balows, A., and Sussman, M., Eds., Arnold, London, 1998, 693–722.
40. Behring, E. and Kitasato, S., Ueber das Zustandekommen der Diptherie-Immunität und der Tetanus-Immunität bei Thieren, Dtsch. Med. Wochenschr., 16, 113–114, 1890.
41. Glenny, A.T., Hamp, A.G., and Stevens, M.F., Protection of horses against tetanus by active immunization with alum toxoid, Vet. J., 88, 90, 1932.
42. Glenny, A.T. et al., Immunological notes, J. Pathol. Bacteriol., 29, 31–40, 1926.
43. Ramon, G. and Lemétayer, E., Sur l’immunité antitétanique naturellement acquise chez quelques expèces de ruminants, C. R. Soc. Biol., 116, 275, 1934.
44. Kerner, C.A.J., Vergiftung durch verdorbene Würste, Tübinger Blättner für naturwissenshcaften und Arzneykunde, 3, 1–45, 1817.
45. Kerner, C.A.J., Das Fettgift oder die Fettsäure und ihre Wirkungen auf den thierischen Organismus, ein Beytrag zur Untersuchung des in verdorgenen Wåursten giftig wirkenden Stoffes, Stuttgart und Tübingen, Cotta 1822.
46. Kessler, K.R. and Benecke, R., Botulinum toxin: from poison to remedy, Neurotoxicology, 18, 761–770, 1997.
47. van Ermengem, E., Ueber einen neuen anaeroben Bacillus and seine Beziehungen zum Botulismus, Z. Hyg. Infektionskh., 26, 1–56, 1897. Abbreviated English translation, Rev. Infect. Dis., 1, 701-719, 1979.
48. Devriese, P.P., On the discovery of Clostridium botulinum, J. Hist. Neurosci., 8, 43–50, 1999.
49. Dewberry, E.B., Food Poisoning. Its Nature, History and Causation Measures for Its Control, Leonard Hill Limited, London, 1950.
50. CDC, Botulism in the United States, 1899–1977, in Handbook for Epidemiologists, Clinicians, and Laboratory Workers, U.S. Dept. Health, Education, Welfare, Public Health Service, Centers for Disease Control and Prevention, Atlanta, GA, 1979.
51. Kempner, W., Further contributions to the knowledge of meat poisoning. The antitoxin to botulism, Z. Hyg. InfektKrankh, 26, 481–500, 1897.
52. Leighton, G.R., Botulism and Food Preservation (the Loch Maree Tragedy), W. Collins & Sons, Ltd, Glasgow, U.K., 1923.
53. Meyer, K.F., The protective measures of the state of California against botulism, J. Prevent. Med., 5, 261–293, 1931.
54. Meyer, K.F., The status of botulism as a world health problem, Bull. Wld. Hlth. Org., 15281–15298, 1956.
55. Meyer, K.F., The rise and fall of botulism, Calif. Med., 118, 63–64, 1973.
56. Meyer, K.F. and Eddie, B., Perspectives concerning botulism, Zeitschr. f Hygiene, Bd., 133, S255–263, 1951.
57. Pickett, J. et al., Syndrome of botulism in infancy: clinical and electrophysiologic study, N. Engl. J. Med., 295, 770–772, 1976.
58. Midura, T.F. and Arnon, S.S., Infant botulism: identification of Clostridium botulinum and its toxin in faeces, Lancet, ii, 934–936, 1976.
59. Davis, J.B., and Mattman, L.H., and Wiley, A.B., Clostridium botulinum in a fatal wound infection, J. Amer. Med. Assoc., 146, 646–648, 1951.
60. Dolman, C.E., Botulism as a world health problem, Botulism. Proceedings of a Symposium, Lewis, H.H., and Casse, K. Jr., Eds., U.S. Dept. Health, Education, and Welfare. Cincinnati, OH, 1964, 5–30.
61. Eklund, M.W. and Dowell, V.R. Jr., Avian Botulism: An International Perspective, Thomas, C.C., Ed. Springfield, IL, 1987.
62. Hatheway, C.L., Botulism, in Laboratory Diagnosis of Infectious Diseases: Principles and Practice, Balows, A. et al., Eds. Springer-Verlag, New York, 1988, 111–133.
63. Johnson, E.A., Anaerobic Fermentations, in Manual of Methods for Industrial Microbiology, 2nd Edition, Demain, A.L. et al., Eds., ASM Press, Washington, DC, 1999.
64. Willis, A.T., Clostridia of Wound Infection, Butterworths, London, 1969.
65. Willis, A.T., Anaerobic Bacteriology: Clinical and Laboratory Practice, 3rd Edition, Butterworths & Co., London, 1977.
66. Dowell, V.R. Jr. and Dezfulian, M., Physiological characterization of Clostridium botulinum and development of practical isolation and identification procedures, in Biomedical Aspects of Botulism, Lewis, G.E.J., Ed., Academic Press, New York, 1981, 205–216.
67. Dowell, V.R. Jr. et al., Media for Isolation, Characterization and Identification of Obligately Anaerobic Bacteria, U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta, 1977.
68. Solomon, H.M. et al., Clostridium botulinum and its toxins, in Compendium for the Microbiological Examination of Foods, 4th Edition, Downes, F.P. and Ito, K., Eds., American Public Health Association, Washington, DC, 2001, 317–324.
69. CDC, Botulism in the United States, 1899–1996, in Handbook for Epidemiologists, Clinicians, and Laboratory Workers, Centers for Disease Control and Prevention, Atlanta, 1998.
70. Eklund, M.W., Poysky, F.T., and Habig, W.H., Bacteriophages and plasmids in Clostridium botulinum and Clostridium tetani and their relationship to production of toxins, in Botulinum Neurotoxin and Tetanus Toxin, Simpson, L.L., Ed., Academic Press, San Diego, 1989, 25–51.
71. Schantz, E.J. and Johnson, E.A., Properties and use of botulinum toxin and other microbial neurotoxins in medicine, Microbiol. Rev., 56, 80–92, 1992.
72. Gunnison, J.B. and Meyer, K.F., The occurrence of nontoxic strains of Cl. parabotulinum, J. Infect. Dis., 45, 77–86, 1929.
73. Gunnison, J.B. and Meyer, K.F., Cultural study of an international collection of Clostridium botulinum and parabotulinum, J. Infect. Dis., 45, 119–134, 1929b.
74. Eklund, M.W., Poysky, F.T., and Habig, W.H., Bacteriophages and plasmids in Clostridium botulinum and Clostridium tetani and their relationship to production of toxins, in Botulinum Neurotoxin and Tetanus Toxin, Simpson, L.L, Ed., Academic Press, San Diego, 1989, 25–51.
75. Goodnough, M.C. et al., Colony immunoblot assay of botulinal toxin, Appl. Environ. Microbiol., 59, 2339–2342, 1993.
76. Holdeman, L.V., Cato, E.P., and Moore, W.E.C., Anaerobe Laboratory Manual, 4th Edition, Department of Anaerobic Microbiology, Virginia Polytechnic Institute and State University, Blacksburg, 1977.
77. Cato, E.P., George, W.L., and Finegold, S.M., Genus Clostridium, in Bergey’s Manual of Systematic Bacteriology, Sneath, P.H.A. et al., Eds., Williams & Wilkins, Baltimore, 1986, 1141–1200.
78. Cato, E.P. and Stackebrandt, E., Taxonomy and phylogeny, in Clostridia, Minton, N.P. and Clarke, D.J., Eds., Plenum Press, New York, 1989, 1–26.
79. DSMZ (Deutsche Sammlung von Mikroorganismen und Zellulturen/German Collection of Microorganisms and Cell Cultures), Bacterial nomenclature, Genus Clostridium, GmbH, Braunschweig, Germany, 2003.
80. Collins, M.D. et al., The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations, Int. J. Syst. Bacteriol., 44, 812–826, 1994.
81. Finegold, S.M., Song. Y., and Liu, C., Taxonomy — General comments and update on taxonomy of clostridia and anaerobic cocci, Anaerobe, 8, 283–285, 2002.
82. Goodfellow, M. and O’Donnell, A.G., Roots of bacterial systematics, in Handbook of New Bacteria Systematics, Goodfellow, M. and O’Donnell, A.G., Eds., Academic Press, London, 1993, 3–54.
83. Giménez, D.F. and Giménez, J.A., The typing of botulinal neurotoxins, Int. J. Food Microbiol., 27, 1–9, 1995.
84. Boroff, D. and Fleck, U., Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum, J. Bacteriol. 92, 1580–1581, 1966.
85. Schantz, E.J. and Kautter, D.A., Standardized assay for Clostridium botulinum toxins, J. Assoc. Off. Anal. Chem., 61, 96–99, 1978.
86. Olive, D. and Bean, P., Principles and applications for DNA-based typing of microbial organisms, J. Clin. Microbiol., 35, 2160–2162, 1999.
87. Wilson, K.H., Molecular biology as a tool for taxonomy, Clin. Infect. Dis., 20, S117–121, 1995.
88. Pourshaban, M. et al., Taxonomic identity of type E botulinum toxin-producing Clostridium butyricum strains by sequencing of a short 16S rDNA region, FEMS Microbiol. Lett., 214, 119–125, 2002.
89. Lin, W.J. and Johnson, E.A., Genome analysis of Clostridium botulinum type A by pulsed-field gel electrophoresis, Appl. Environ. Microbiol., 61, 4441–4447, 1995.
90. Hielm, S. et al., Genomic analysis of Clostridium botulinum group II by pulsed-field gel electrophoresis, Appl. Environ. Microbiol., 64, 703–708, 1998.
91. Hielm, S. et al., Prevalence of Clostridium botulinum in Finnish trout farms: pulsed-field gel electrophoresis typing reveals extensive genetic diversity among type E isolates, Appl. Environ. Microbiol., 64, 4161–4167, 1998.
92. Franciosa, G., Aureli, P., and Schechter, R., Clostridium botulinum, in International Handbook of Foodborne Pathogens, Miliotis, M.D. and Bier, J.W., Eds., Marcel Dekker, New York and Basel, 2003, 61–89.
93. Fenicia, L. et al., A case of infant botulism due to neurotoxigenic Clostridium butyricum type E associated with Clostridium difficile colitis, Eur. J. Microbiol. Infect. Dis., 21, 736–738, 2002.
94. Fenicia, L. et al., Intestinal toxemia botulism in two young people caused by Clostridium butyricum type E, Clin. Infect. Dis., 154, 207–211, 1999.
95. Chaudry, R. et al., Outbreak of suspected Clostridium butyricum botulism in India, Emerg. Infect. Dis., 4, 506–507, 1998.
96. Harvey, S.M., Sturgeon, J., and Dassey, D.E., Botulism due to Clostridium botulinum type F toxin, J. Clin. Microbiol., 40, 2260–2262, 2002.
97. Meng, X. et al., Isolation and characterization of neurotoxigenic Clostridium butyricum from soil in China, J. Med. Microbiol., 48, 133–137, 1999.
98. Barash, J.R. and Arnon, S.S., Dual-toxin producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism, J. Clin. Microbiol., 42, 1713–1715, 2004.
99. Wang, X. et al., Genetic analysis of type E botulinum toxin-producing Clostridium butyricum strains, Appl. Environ. Microbiol., 66, 4992–4997, 2000.
100. Johnson, E.A., Bacteriophages encoding botulinum and diphtheria toxin, in Bacteriophages and Bacterial Pathogens, Waldor, M., Friedman, A., and Adhya, S., Eds., ASM Press, Inc., Washington, DC, in press.
101. Dodds, K.L., Clostridium botulinum in the environment, in Clostridium botulinum: Ecology and Control in Foods, Hauschild, A.H.W. and Dodds, K.L., Eds., Marcel Dekker, New York, 1993, 105–117.
102. Easton, E.J. and Meyer, K.F., Occurrence of Bacillus botulinus in human and animal excreta, J. Infect. Dis., 35, 207–212, 1924.
103. Calabi, E. and Fairweather, N., Patterns of sequence conservation in the S-layer proteins and related sequences in Clostridium difficile, J. Bacteriol., 184(14), 3886–3897, 2002.
104. Takumi, K. et al., Characterization, self-assembly and reattachment of S layer from Clostridium botulinum type E saroma, Tokushima J. of Exp. Med., 39(3–4), 101–107, 1992.
105. Setlow, P. and Johnson, E.A., Spores and their significance, in Food Microbiology: Fundamentals and Frontiers, Doyle, M.P., Beuchat, L.R., and Montville, T., Eds., ASM Press, Washington, DC, 2001.
106. Woods, D.R. and Jones, D.T., Physiological responses of Bacteroides and Clostridium strains to environmental stress, Adv. Microbiol. Physiol., 28, 1–64, 1986.
107. Kihm, D. et al., Zinc stimulates sporulation of Clostridium botulinum 113B, Curr. Microbiol., 17, 193–198, 1998.
108. Ito, K.A. et al., The thermal and germicidal resistance of Clostridium botulinum types A, B, and E spores, in Proceedings of the First U.S.-Japan Conference on Toxic Micro-Organisms, Herzberg, M., Ed., UJNR Joint Panels on Toxic Micro-Organisms and U.S. Dept. Interior, Washington, DC, 1968.
109. Lund, B.M. and Peck, M.W., Clostridium botulinum, in The Microbiological Safety and Quality of Food, Vol II, Lund, B.M., Baird-Parker, T.C., and Gould. G.W., Eds., Aspen Publishers, Inc., Gaithersburg, MD, 2000, 1057–1109.
110. Kim, J. and Foegeding, P.M., Principles of Control: Ecology and Control in Foods, Hauschild, A.H.W. and Dodds, K.L., Eds., Marcel Dekker, New York, 1993, 121–176.
111. Rood, J.I., Virulence genes of Clostridium perfringens, Annu. Rev. Microbiol., 52, 333–360, 1998.
112. Zhou, Y., et al., The genes for the Clostridium botulinum type G toxin complex are on a plasmid, Infect. Immun., 63, 2087–2209, 1995.
113. Eklund, M.W. et al., Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G, Appl. Environ. Microbiol., 54, 1405–1408, 1988.
114. Laird, W.J. et al., Plasmid-associated toxigenicity in Clostridium tetani, J. Infect. Dis., 142, 623, 1980.
115. Dineen, S.S., Bradshaw, M., and Johnson, E.A., Cloning, nucleotide sequence, and expression of the gene encoding bacteriocin boticin B from Clostridium botulinum strain 213B, Appl, Environ, Microbiol., 66, 5480–5483, 2000.
116. Adams, M.H., Bacteriophages, Wiley Interscience, New York, 1959.
117. Johnson, E.A., Extrachromosomal virulence determinants in the clostridia, in Molecular Genetics and Pathogenesis of the Clostridia, Rood, J. et al., Eds., Academic Press, London, 1997.
118. Johnson, E.A., et al., Characterization of neurotoxin mutants in Clostridium botulinum type A, Clin. Infect. Dis., 25 (Suppl. 2), S168–170, 1997.
119. Canchaya, C. et al., Phages as agents of lateral gene transfer, Curr. Opin. Microbiol., 6, 417–424, 2003.
120. Gentry-Weeks, P., Coburn, S., and Gilmore. M.S., Phages and other mobile virulence elements in Gram-positive pathogens, Curr. Top. Microbiol. Immunol., 264, 79–94, 2002.
121. Hauser, D. et al., Plasmid localization of a type E botulinal neurotoxin gene homologue in toxigenic Clostridium butyricum strains, and absence of this gene in non-toxigenic C. butyricum strains, FEMS Microbiol. Lett., 99, 252–256, 1992.
122. Hauser, D. et al., Botulinal toxin genes, clostridial neurotoxin homology and genetic transfer in Clostridium botulinum, Toxicon, 33, 515–526, 1995.
123. Zhou, Y., Sugiyama, H., and Johnson. E.A., Transfer of neurotoxigenicity from Clostridium butyricum to a nontoxigenic Clostridium botulinum type E-like strain, Appl. Environ. Microbiol., 59, 3825–3831, 1993.
124. Kautter, D.A. et al., Antagonistic effect on Clostridium botulinum type E by organisms resembling it, Appl. Microbiol., 14, 616–622, 1966.
125. Eklund, M.W. et al., Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G, Appl. Environ. Microbiol., 54, 1405–1408, 1988.
126. Adams, E.B., Lawrence, D.R., and Smith, J.W.G., Tetanus, Blackwell Scientific, Oxford, 1969.
127. Mitsui, N., Mitsui, K., and Hase, J., Purification and some properties of tetanolysin, Microbiol. Immunol., 24, 575–584, 1980.
128. Brüggeman, H. and Gottschalk, G., Insights in metabolism and toxin production from the complete genome sequence of Clostridium tetani, Anaerobe, 10, 53–68, 2004.
129. Dezfulian, M., Animal models of botulism and tetanus, in Botulinum Neurotoxin and Tetanus Toxin, Simpson, L.L., Ed., Academic Press, San Diego, 1989, 335–350.
130. Gill, D.M., Bacterial toxins: a table of lethal amounts, Microbiol. Rev., 46, 86–94, 1982.
131. Sakaguchi, G., Clostridium botulinum toxins, Pharmacol. Ther., 19, 165–194, 1983.
132. Giménez, D.F. and Giménez, J.A., Serological subtypes of botulinal neurotoxins, in Botulism and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects, DasGupta, B.R., Ed., Plenum Press, New York, 1993.
133. Malizio, C.J., Goodnough, M.C., and Johnson, E.A., Purification of Clostridium botulinum type A neurotoxin, in Bacterial Toxins: Methods and Protocols, Meth. Molec. Biol., Vol. 145, Holst, O., Ed., Humana Press Inc., Totowa, NJ, 2000, 27–39.
134. Holdeman, L.V. and Brooks, J.B., Variation among strains of Clostridium botulinum and related clostridia, in Proceedings of the First U.S.-Japan Conference on Toxic Microorganisms, Herzberg, M., Ed., U.S. Government Printing Office, Washington, DC, 1970, 278–286.
135. Giménez, D.F. and Ciccarelli, A.S., Another type of Clostridium botulinum, Zentralbl Bakteriol I, Abt Orig A, 215, 221–224, 1970.
136. Ciccarelli, A.S. et al., Cultural and physiological characterization of Clostridium botulinum type G and the susceptibility of certain animals to its toxin, Appl. Environ. Microbiol., 34, 843–848, 1977.
137. Gimenez, D.F. and Ciccarelli, A.S. Studies on strain 84 of Clostridium botulinum. Zentralblatt Bakteriol., Parasit., Infektionsk. Hyg.-1-Abt-Mediz.-Hyg. Bakteriol., Virusfors. Parasit.-Orig., 215(2), 212–220, 1970.
138. ICMSF (International Commission for Microbiological Safety of Foods), Microorganisms in Foods 5, Characteristics of Microbial Pathogens, Blackie Academic & Professional, London, 1996, 66–111.
139. Glass, K.A. and Johnson, E.A., Formulating low-acid foods for botulinal safety, in Control of Foodborne Organisms, Juneja, V.K. and Sofos, J.N., Eds., Marcel Dekker, New York, 2001, 323–350.
140. Townsend, C.T., Yee, L., and Mercer, W.A., Inhibition of the growth of Clostridium botulinum by acidification, Food. Res., 19, 536–542, 1954.
141. Bell, C. and Kyriakides, A., Clostridium botulinum: A Practical Approach to the Organism and Its Control in Foods, Blackwell Science, Ltd., Oxford, 2000.
142. Popoff, M.R., Ecology of neurotoxigenic strains of clostridia, in Clostridial Neurotoxins, Montecucco, C., Ed., Springer, Berlin, 1995, 1–29.
143. Whitmer, M.E. and Johnson, E.A., Development of improved defined media for Clostridium botulinum serotypes A, B, and E, Appl. Environ. Microbiol., 54, 753–759, 1988.
144. Patterson-Curtis, S.I. and Johnson, E.A., Roles of arginine in growth of Clostridium botulinum type B, Appl. Environ. Microbiol., 58, 2334–2337, 1992.
145. Patterson-Curtis, S.I. and Johnson, E.A., Regulation of neurotoxin and protease formation in Clostridium botulinum Okra B and Hall A by arginine, Appl. Environ. Microbiol., 55, 1544–1548, 1989.
146. Leyer, G.J. and Johnson, E.A., Repression of toxin production by tryptophan in Clostridium botulinum type E, Arch. Microbiol., 154, 443–447, 1990.
147. Dolman, C.E., Growth and metabolic activities of Clostridium botulinum types in Botulism, in Proc. of Symp., Cincinnati, Ohio, Jan. 1964, Lewis, K.H. and Cassel, K. Jr., Eds., Public Health Service Publication No. 999-FP-1, PHS, Cincinnati, 1964, 43–68.
148. Eklund, M.W., Wieler, D.I., and Poysky, F.T., Outgrowth and toxin production of non-proteolytic type B Clostridium botulinum at 3.3 – 5.6 deg.C, J. Bacteriol., 93, 1461–1462, 1967.
149. Ohye, D.F. and Scott, W.J., Studies on the physiology of Clostridium botulinum type E, Aust. J. Biol. Sci., 10, 85–94, 1957.
150. Lynt, R.K., Kautter, D.A., and Solomon, H.M., Differences and similarities among proteolytic and nonproteolytic strains of Clostridium botulinum types A, B, E, and F: a review, J. Food. Prot., 45, 466–474, 1982.
151. Mead, G.C., The amino acid-fermenting clostridia, J. Gen. Microbiol., 67, 47–56, 1971.
152. Inoue, K. and Iida, H., Conversion of toxigenicity in Clostridium botulinum type C, Jpn., J. Microbiol., 14, 87–89, 1970.
153. Oguma, K. et al., Structure and function of Clostridium botulinum progenitor toxin. J. of Tox.-Tox. Rev. 18(1), 17–34, 1999.
154. Glasby, C. and Hatheway, C.L. Flourescent antibody reagents for the identification of Clostridium botulinum, J. of Clin. Microbiol.,18, 1378–1383, 1983.
155. Suen, J.C. et al., Clostridium argentinense, sp. nov.: a genetically homogenous group composed of all strains of Clostridium botulinum toxin type G and some nontoxigenic strains previously identified as Clostridium subterminale or Clostridium hastiforme, Int. J. Syst. Bacteriol., 38, 375–381, 1988.
156. Nukina, M. et al., Purification of Clostridium botulinum type G progenitor toxin, Zbl. Bakt. Hyg. A., 268, 220–227, 1988.
157. Malizio, C.J., Sugiyama, H., and Johnson, E.A., unpublished data, 1996.
158. Schiavo, G. et al., Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single ala-ala peptide bond, J. Biol. Chem., 269, 20213–20216, 1994.
159. Aureli, P. et al., Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy, J. Infect. Dis., 154, 207–211, 1986.
160. McCroskey, L. and Hatheway, C.L., et al., Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism, J. Clin. Microbiol., 23, 201–202, 1986.
161. Hall, J.D. et al., Isolation of an organism resembling Clostridium barati which produces type F botulinal toxin from an infant with botulism, J. Clin. Microbiol., 21, 654–655, 1985.
162. McCroskey, L.M. et al., Type F botulism due to neurotoxigenic Clostridium baratii from an unknown source in an adult, J. Clin. Microbiol., 29, 2618–2620, 1991.
163. Harvey, S.M., Sturgeon, J., and Dassey, D.E., Botulism due to Clostridium botulinum type F toxin, J. Clin. Microbiol., 40, 2260–2262, 2002.
164. Paisley, J.W., Lauer, B.A., and Arnon, S.S., A second case of infant type F botulism caused by Clostridium baratii, The Pediatr. Inf. Dis. J., 14, 912–914, 1995.
165. Giménez, J.A. and Sugiyama, H., Simplified purification method for Clostridium botulinum type E toxin, Appl. and Environ. Microbiol. 53, 2827–2830, 1987.
166. Giménez, J.A., Gimenez, M.A., and DasGupta, B.R., Characterization of the neurotoxin isolated from a Clostridium baratii strain implicated in infant botulism, Infect. Immun. 60, 518–522, 1992.
167. Scott, A.B. and Suzuki, D., Systemic toxicity of botulinum toxin by intramuscular injection in the monkey, Movement Disord., 3, 333–335, 1988.
168. Herrero, B.A. et al., Experimental botulism in monkeys — a clinical pathological study, Exp. Mol. Path., 6, 84–95, 1967.
169. Larson, A.E. and Johnson, E.A., Review of oral toxicity of botulinum toxin in primates, (Unpublished Review), 2004.
170. Ferreira, J.L. et al., Detection of botulinal neurotoxins A, B, E, and F by amplified enzyme-linked immunosorbent assay: collaborative study, J. AOAC Int., 86(2), 314–331, 2003.
171. Ketema, F. et al., Assessment of the performance of a rapid, lateral flow assay for the detection of antibodies to HIV, J. Acq. Imm. Deficien. Sys., 27, 63–70, 2001.
172. Sharma, S. K. et al., Evaluation of lateral flow Clostridium botulinum neurotoxin detection kits for food analysis, Appl. Environ. Microbiol., in press, 2004.
173. Anne, C. et al., High-throughput fluorigenic assay for determination of botulinum type B neurotoxin protease activity, Anal. Biochem., 291, 253–261, 2001.
174. Schmidt, J.J. and Stafford, R.G. Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F., Appl. Environ. Microbiol., 69(1), 297–303, 2003. [Erratum appears in Appl. Environ. Microbiol. 69, 3025, 2003.]
175. Barr, J., Characterization of botulinum neurotoxins by mass spectroscopy, personal communication, 2004.
176. Moorthy, J. et al., Microfluidic tectonics platform: a colorimetric, disposable botulinum toxin enzyme-linked immunosorbent assay system, Electrophoresis, 25, 1705–1713, 2004.
177. Liu, W. et al., Botulinum toxin type B micromechanosensor, Proc. Natl. Acad. Sci. U.S.A., 100, 13621–13625, 2003.
178. Centers for Disease Control/National Institutes of Health, Biosafety in Microbial and Biomedical Laboratories, 4th Edition, U.S. Dept. of Health and Human Services, Washington, DC, 1993.
179. Johnson, E.A., Extrachromosomal virulence determinants in the clostridia, in Molecular Genetics and Pathogenesis of the Clostridia, Rood, J. et al., Eds., Academic Press, London, 1997.
180. Matsuda, M., The structure of tetanus toxin, in Botulinum Neurotoxin and Tetanus Toxin, Simpson, L.L., Ed., Academic Press, San Diego, 1989, 69–92.
181. Sugiyama, H., Clostridium botulinum neurotoxin, Microbiol. Rev., 44, 419–448, 1980.
182. Dineen, S.S., Bradshaw M., and Johnson, E.A., Neurotoxin gene clusters in Clostridium botulinum type A strains: sequence comparison and evolutionary implications, Curr. Microbiol., 46, 345–352, 2003.
183. Dineen, S.S. et al., Nucleotide sequence and transcriptional analysis of the type A2 neurotoxin gene cluster in Clostridium botulinum, FEMS Microbiol. Lett., 235, 9–16, 2004.
184. Schantz, E.J. and Johnson, E.A., Botulinum toxin: the story of its development for the treatment of human disease, Perspectives Biol. Med., 40, 317–327, 1997.
185. 125I-botulinum-free neurotoxin: time course of tissue distribution, Toxicon, 42, 461–469, 2003.
186. Wohlfarth, K., Kampe, K., and Bigalke, H., Pharmacokinetic properties of different formulations of botulinum neurotoxin type A, Mov. Disor., 19 Suppl 8, S65–67, 2004.
187. DasGupta, B.R. and Sugiyama, H., Inhibition of Clostridium botulinum types A and B hemagglutinins by sugars, Can. J. Microbiol., 23(9), 1257–1260, 1977.
188. Kozaki, S. et al., Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins, Microbial Path., 25, 91–99, 1998.
189. Emsley, P. et al., The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding, J. Biol. Chem., 275(12), 8889–8894, 2000.
190. Kubota, T. et al., Gene arrangement in the upstream region of Clostridium botulinum type E and Clostridium butyricum BL 6340 progenitor toxin gene is different from that of other types, FEMS Microbiol. Lett., 158, 215–221, 1998.
191. Raffestin, S. et al., Organization and regulation of the neurotoxin genes in Clostridium botulinum and Clostridium tetani, Anaerobe, 10, 93–100, 2004.
192. Popoff, M.R. and Marvaud, J.-C., Structural and genomic features of clostridial neurotoxins, in The Comprehensive Sourcebook of Bacterial Protein Toxins, Alouf, J.E. and Freer, J.H., Eds., Academic Press, London, 1999, 174–201.
193. Franciosa, G., Ferreira, J.L., and Hatheway, C.L., Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR — evidence of unexpressed type B toxin genes in type A toxigenic organisms, J. Clin. Microbiol., 32, 1911–1917, 1994.
194. Hutson, R.A. et al., Genetic characterization of Clostridium botulinum type A containing silent B neurotoxin gene sequences, J. Biol. Chem., 271, 10786–10792, 1996.
195. Moriishi, K. et al., Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms, Biochim. Biophys. Acta, 1307, 123–126, 1996.
196. Bradshaw, M., Dineen, S.S., Maks, N.D., and Johnson, E.A., Regulation of neurotoxin complex expression in Clostridium botulinum strains 62A, Hall A-hyper, and NCTC 2916, Anaerobe, 10, 321–333, 2004.
197. Lin, W.-J. and Johnson, E.A., Transposon Tn916 mutagenesis in Clostridium botulinum, Appl. Environ. Microbiol., 57, 2946–2950, 1991.
198. Mueller, J.H. and Miller, P.A., Growth requirements of Clostridium tetani, J. Bacteriol., 43, 763–772, 1942.
199. Mueller, J.H. and Miller, P.A., Production of tetanal toxin, J. Immunol., 50, 377–384, 1945.
200. Mueller, J.H. and Miller, P.A., Unidentified nutrients in tetanus toxin production, J. Bacteriol., 56, 219–233, 1948.
201. Mueller, J.H. and Miller, P.A., Essential role of histidine peptides in tetanus toxin production, J. Biol. Chem., 223, 763–772, 1956.
202. Porfirio, Z. et al., Specific peptides of casein pancreatic digestion enhance the production of tetanus toxin, J. Appl. Microbiol., 83, 678–684, 1997.
203. Lewis, K.H. and Hill, E.V., Practical media and control measures for producing highly toxic cultures of Clostridium botulinum type A, J. Bacteriol., 53, 213–230, 1947.
204. Bradshaw, M., Goodnough, M.C., and Johnson, E.A., Conjugative transfer of the E. coli-C. perfringens shuttle vector pJIR1457 to Clostridium botulinum type A strains, Plasmid, 40, 233–237, 1998.
205. Marvaud, J.C. et al., TetR is a positive regulator of the tetanus toxin gene in Clostridium tetani and is homologous to botR, Infect. Immun. 66, 5698–5702, 1998.
206. Marvaud, J.C. et al., botR/A is a positive regulator of botulinum neurotoxin and associated non-toxin protein genes in Clostridium botulinum A, Mol. Microbiol., 29,1009–1018, 1998.
207. Marvaud, J.C. et al., Regulation of the toxinogenesis in Clostridium botulinum and Clostridium tetani, Biol. Cell, 92, 455–457, 2000.
208. Wosten, M.M. et al., A signal transduction system that responds to extracellular iron, Cell, 103, 113–125, 2000.
209. Helman, J.D., The extracytoplasmic function (ECF) sigma factors, Adv. Microbiol. Physiol., 46, 47–110, 2002.
210. Dupuy, B. and Sonenshein, A.L., Regulated transcription of Clostridium difficile toxin genes, Mol. Microbiol., 27,107–120, 1998.
211. Garneir, T. and Cole, S.T., Studies of UV-inducible promoters from Clostridium perfringens in vivo and in vitro, Mol. Microbiol., 2, 607–614, 1988.
212. Karlsson, S., Burman, L.G., and Akerlund, T., Suppression of toxin production in Clostridium difficile VPI10463 by amino acids, Microbiol., 145, 1683–1693, 1999.
213. Karlsson, S. et al., Expression of Clostridium difficile toxins A and B and their sigma factor TcdD is controlled by temperature, Infect. Immun., 71, 1784–1793, 2003.
214. Mani, N. and Dupuy, B., Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor, Proc. Natl. Acad. Sci. U.S.A., 98, 5844–5849, 2001.
215. Mani, N. et al., Environmental response and autoregulation of Clostridium difficile TxeR, a sigma factor for toxin gene expression, J. Bacteriol., 184, 5971–5978, 2003.
216. DasGupta, B.R. and Boroff, D.A., Separation of toxin and hemagglutin from crystalline toxin of Clostridium botulinum type A by anion exchange chromatography and determination of their dimensions by gel filtration, J. Biol. Chem., 243, 1065–1072, 1968.
217. DasGupta, B.R. and Sugiyama, H., A common subunit structure in Clostridium botulinum type A, B, and E toxins, Biochem. Biophys. Res. Commun., 48, 108–112, 1971.
218. DasGupta, B.R. and Sugiyama, H., Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures, Infect. Immun., 14, 680–686, 1976.
219. DasGupta, B.R. and Dekleva, M.L., Botulinum neurotoxin type A: sequence of amino acids at the N-terminus and around the nicking site, Biochimie, 72, 661–664, 1990.
220. DasGupta, B.R. and Foley, J. Jr., C. botulinum neurotoxin types A and E: isolated light chain breaks down into two fragments. Comparison of their amino acid sequences with tetanus neurotoxin, Biochimie, 71, 1193–1200, 1989.
221. Ahmed, S.A. et al., Enzymatic autocatalysis of botulinum A neurotoxin light chain, J. Protein Chem., 3, 221–231, 2001.
222. Kurazano, H. et al., Minimal essential domains specifying toxicity of the light chains of tetanus toxin and botulinum neurotoxin type A, J. Biol. Chem., 267, 14721–14729, 1992.
223. Baldwin, M.R. et al., The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis and stability, Protein Express. Purif., 37, 187–195, 2004.
224. Montecucco, C., On the enzymatic activity of tetanus toxin, Toxicon, 25, 1255–1257, 1987.
225. Niemann, H., Molecular biology of clostridial neurotoxins, in A Sourcebook of Bacterial Protein Toxins, Alouf, J.E. and Freer, J.H., Eds., Academic Press., London, 1991, 303–348.
226. Collins, M.D. and East, A.K., Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurtoxins, J. Appl. Microbiol., 84, 5–17, 1998.
227. Lacy, D.B. and Stevens, R.C., Sequence homology and structural analysis of the clostridial neurotoxins, J. Mol. Biol., 291, 1091–1104, 1999.
228. Schiavo, G. et al., Botulinum neurotoxins are zinc proteins, J. Biol. Chem., 267, 23479–23483, 1992.
229. Wright, J.F. et al., Identification and partial characterization of a low affinity metal-binding site in the light chain of tetanus toxin, J. Biol. Chem., 267, 9053–9058, 1992.
230. Rossetto, O., Tonello, F., and Montecucco, C., Proteases, in Bacterial Protein Toxins, Burns, D.L. et al., Eds., ASM Press, Washington, DC, 2003, 271–282.
231. Poulain, B. et al., Inhibition of neurotransmitter release by botulinum neurotoxins and tetanus toxin at Aplysia synapses: role of constituent chains, J. Physiol., 84, 247–261, 1990.
232. Sutton, R.B. et al., Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution, Nature, 395, 347–353, 1998.
233. Sollner, T.H., Regulated exocytosis and SNARE function, Mol. Membrane Biol., 20, 209–220, 2003.
234. Matthews, B.W., Structural basis of the action of thermolysin and related zinc peptidases, Acc. Chem. Res., 21, 333–340, 1988.
235. Keller, J.E., Cai, F., and Neale, E.A., Uptake of botulinum neurotoxin into cultured neurons, Biochem, 43, 526–532, 2004.
236. Foran, P.G. et al., Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons, J. Biol. Chem., 278, 1363–1371, 2003.
237. Chen, F., et al., Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms, Infect. Immun., 65, 1626–1630, 1997.
238. Byrne, M.P. and Smith, L.A., Development of vaccines for prevention of botulism, Biochimie, 82, 955–966, 2000.
239. Lacy, D.B. et al., Crystal structure of botulinum neurotoxin type A and implications for toxicity, Nat. Struct. Biol., 5, 898–902, 1998.
240. Hanson, M.I. and Stevens, R.C., Structural view of botulinum neurotoxin in numerous functional states, in Scientific and Therapeutic Aspects of Botulinum Toxin, Brin, M.F., Hallett, M., and Jankovic, J., Eds., Lippincott, Williams & Wilkins, Philadelphia, 2002.
241. Burkard, F. et al., Electron density projection map of the botulinum neurotoxin 900-kilodalton complex by electron crystallography, J. Struct. Biol., 120, 78–84, 1997.
242. Segelke, B. et al., Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity, Proc. Natl. Acad. Sci. U.S.A., 101, 6888–6893, 2004.
243. Swaminathan, S. and Eswaramoorthy, S., Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B, Nat. Struct. Biol., 7, 693–699, 2000.
244. Knapp, M., Segelke, B., and Rupp, B., The 1.61 Angstrom structure of the tetanus toxin ganglioside binding region: solved by MAD and MIR phase combination, Am. Cryst. Assoc. Papers, 25, 90, 1998.
245. Rupp, B. and Segelke, B., Questions about the structure of the botulinum neurotoxin B light chain in complex with a target peptide, Nat. Struct. Biol., 8, 663–664, 2001.
246. C of tetanus neurotoxin, Nat. Struct. Biol., 4, 788–792, 1997.
247. Nishiki, T. et al., Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA, Neurosci. Lett., 208, 105–108, 1996.
248. Dong, M. et al., Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells, J. Cell Biol., 162, 1293–1303, 2003.
249. Koriazova, L.K. and Montal, M., Translocation of botulinum neurotoxin light chain protease through the heavy chain channel, Nat. Struct. Biol., 10, 13–18, 2003.
250. Puhar, A. et al., Comparison of the pH-induced conformational change of different clostridial neurotoxins, Biochem. Biophys. Res. Commn., 319, 66–71, 2004.
251. Caccin, P. et al., VAMP/synaptobrevin cleavage by tetanus and botulinum neurotoxins is strongly enhanced by acidic liposomes, FEBS Lett., 542, 132–136, 2003.
252. Fernandez-Salas, E. et al., Plasma membrane localization signals in the light chain of botulinum neurotoxin, Proc. Natl. Acad. Sci. U.S.A., 101, 3208–3213, 2004.
253. Koh, J.Y., Zinc and disease of the brain, Mol. Neurobiol., 24, 99–106, 2001.
254. Ferrer-Montiel, A.V. et al., Tyrosine phosphorylation modulates the activity of clostridial neurotoxins, J. Biol. Chem., 271, 18322–18325, 1996.
255. Encinar, J.A. et al., Structural stabilization of botulinum neurotoxins by tyrosine phosphorylation, FEBS Lett., 429, 78–82, 1998.
256. Patrick III, W.C., Analysis of botulinum toxin, type A, as a biological warfare threat, unpublished report, 1998.
257. Sugishima, M., Aum Shinrikyo and the Japanese law on bioterrorism, Prehospital Disast. Med., 18, 179–183, 2003.
258. Broussard, L.A., Biological agents: weapons of warfare and bioterrorism, Mol. Diag., 6, 323–333, 2001.
259. Atlas, R.M., Bioterrorism and biodefence research: changing the focus of microbiology, Nat. Rev. Microbiol., 1, 70–74, 2003.
260. Covert, N.M., Cutting Edge—A History of Fort Detrick, Maryland 1943–1993, Public Affairs Office, Fort Detrick, 1994.
261. Alibek, K. and Handleman, S., Biohazard, Random House, New York, 1999.
262. Caya, J.G., Clostridium botulinum and the ophthalmologist: a review of botulism, including biological warfare ramifications of botulinum toxin, Survey Ophthal., 46, 25–34, 2001.
263. Bernard, C., Analyse physiologique des propriétés des systèmes musculaire et nerveux au moyen du curare, C. R. Acad. Sci. (Paris), 43, 825–829, 1856.
264. Bernard, C., An Introduction to the Study of Experimental Medicine, translated by Green, H.C., The MacMillan Company, New York, 1927.
265. Scott, A.B., Rosenbaum, A., and Collins, C.C., Pharmacologic weakening of extraocular muscles, Invest. Ophthal., 12, 924–927, 1973.
266. Scott, A.B., Botulinum toxin injection into extraocular muscles as an alternative to surgery, Opthamol., 87, 1044–1049, 1980.
267. Scott, A.B., Botulinum toxin injection of eye muscles to correct strabismus, Trans. Am. Opthal. Soc., 79, 734–740, 1981.
268. Borodic, G.E., Acquadro, M., and Johnson E.A., Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects, Expert. Opin. Invest. Drugs, 10, 1531–1544, 2001.